dr. gradishar comments on the treatment of early stage breast cancer with endocrine therapy
Published 10 years ago • 417 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
1:44
dr. gradishar discusses the treatment of her2 breast cancer
-
2:21
dr. gradishar discusses advances in the treatment of her2-positive breast cancer
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
1:38
dr. william gradishar discusses the eribulin and capecitabine 301 study
-
1:22
dr. william gradishar discusses 10 years of adjuvant tamoxifen
-
2:09
dr. william gradishar on updates in nccn breast cancer guidelines
-
1:49
dr. gradishar on selecting agents for her2 breast cancer
-
0:47
dr. william gradishar on the importance of enriching clinical trials
-
4:01
duration of endocrine therapy in breast cancer
-
0:54
dr. goldstein on endocrine resistance therapy in early- stage breast cancer
-
1:57:47
drs. hamilton, gradishar, rugo, & schmid discuss #breastcancer at #sabcs22 - http://bit.ly/3zedpm8
-
7:44
hormonal and her2-targeted therapy in early breast cancer
-
0:50
dr. gradishar discusses dual her2-targeting in breast cancer
-
0:42
role of endocrine therapy in early-stage hr-positive breast cancer
-
1:26
dr. burstein on adjuvant endocrine therapy for er breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
5:15
mechanisms and implications of her2 resistance - an interview with dr. william gradishar
-
0:51
dr. goetz on treatment of metastatic hr breast cancer
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer